Skip to main content

The Use of Systemic and Topical Fluoroquinolones.

Publication ,  Journal Article
Jackson, MA; Schutze, GE; COMMITTEE ON INFECTIOUS DISEASES,
Published in: Pediatrics
November 2016

Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatrics

DOI

EISSN

1098-4275

ISSN

0031-4005

Publication Date

November 2016

Volume

138

Issue

5

Start / End Page

e20162706

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Treatment Outcome
  • Risk Assessment
  • Pediatrics
  • Patient Safety
  • Male
  • Humans
  • Fluoroquinolones
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jackson, M. A., Schutze, G. E., & COMMITTEE ON INFECTIOUS DISEASES, . (2016). The Use of Systemic and Topical Fluoroquinolones. Pediatrics, 138(5), e20162706. https://doi.org/10.1542/peds.2016-2706
Jackson, Mary Anne, Gordon E. Schutze, and Gordon E. COMMITTEE ON INFECTIOUS DISEASES. “The Use of Systemic and Topical Fluoroquinolones.Pediatrics 138, no. 5 (November 2016): e20162706. https://doi.org/10.1542/peds.2016-2706.
Jackson MA, Schutze GE, COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016 Nov;138(5):e20162706.
Jackson, Mary Anne, et al. “The Use of Systemic and Topical Fluoroquinolones.Pediatrics, vol. 138, no. 5, Nov. 2016, p. e20162706. Epmc, doi:10.1542/peds.2016-2706.
Jackson MA, Schutze GE, COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016 Nov;138(5):e20162706.

Published In

Pediatrics

DOI

EISSN

1098-4275

ISSN

0031-4005

Publication Date

November 2016

Volume

138

Issue

5

Start / End Page

e20162706

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Treatment Outcome
  • Risk Assessment
  • Pediatrics
  • Patient Safety
  • Male
  • Humans
  • Fluoroquinolones
  • Female